With cases of Covid-19 reaching new heights in the world, some states have to adapt rapidly with their rules and regulations. After seeking advice from the some agency and venue hotel, also considering the traffic control and epidemic prevention, the committee must admit this May is not a good time for holding an event. So after serious consideration, the organizing committee decides to postpone this meeting to May 10-12, 2023 at Tokyo, Japan. Sincerely hope you can understand such a demanded action.
Apart from protecting our participants, rescheduling non-essential gathering and travel also aims to contain the spread of coronavirus disease and protect the health system which will otherwise be overwhelmed. Thank you very much for your understanding in the complex situation.
Event Committee
The Annual Congress of International Drug Discovery Science &Technology (IDDST) initiated since 2003, it has been successfully hosted in Shanghai (China), Beijing (China), Shenzhen (China), Nanjing (China), Haikou (China), Suzhou (China), Xi’an (China), Gyeonggi (South Korea), Osaka (Japan), Boston (USA) and Kyoto (Japan) and has attracted more than 10,000 participants from over 50 countries and regions in the previous 18 years. This year, the 19th Annual Congress of International Drug Discovery Science & Technology-2022 (IDDST-2022) will be held during May 11-13, 2022 at Tokyo, Japan.
 |
Dr. H. Michael Shepard, President & CEO, Enosi Life Sciences, USA |
 |
Dr. Tom Blundell, Professor, University of Cambridge, UK |
 |
Dr. Ulo Langel, Professor, Stockholm University, Sweden |
 |
Dr. Mats Larsson, Professor, Department of Physics, Stockholm University, Sweden |
 |
Dr. Maria Koufali, Managing Director, Research and Innovation, Nottingham University Hospitals NHS Trust, UK |
 |
Dr. Ferenc Hudecz, Professor, Department of Organic Chemistry, Eötvös L. University, Hungary |
 |
Dr. Sergey Suchkov, Professor, A.I.Evdokimov Moscow State University of Medicine & Dentistry, Russia |
 |
Dr. Jian Yang, Senior Director, Digital Heath, Eli Lilly and Company, USA |
 |
Dr. Yehuda Shoenfeld, Professor, Sheba Medical Center, Tel-Aviv University, Israel |
 |
Dr. Arne Staby, Scientific VP, CMC Project Management, Biologics, Novo Nordisk A/S, Denmark |
 |
Dr. Michael Markert, Vice President and Global Head of CardioMetabolic Diseases Research, Boehringer Ingelheim, Germany |
 |
Dr. Chuang Kee Ong, Associate Director, Centre of Genomics Research, AstraZeneca UK Limited, UK |
 |
Dr. Ved Srivastava, Vice President of Peptide Chemistry, Intarcia Therapeutics, USA |
 |
Dr. Sylvie Pucheu, Founder and CSO, CILcare, France |
 |
Dr. Andreas Seidl, Chief Operating Officer, Leukocare AG, Germany |
 |
Dr. Wilfried Dathe, External Consultant and Head of Medical Research, Heck Bio-Pharma GmbH, Germany |
 |
Dr. Tomoko Mineno, Professor, Takasaki University of Health and Welfare, Japan |
 |
Dr. Richard Denk, Senior Consultant, Aseptic Processing & Containment, SKAN AG, Switzerland |
 |
Dr. Klaus Groschner, Professor, Chair of Biophysics, Medical University of Graz, Austria |
 |
Dr. Yiqun Li, Head of IT Lilly Biotechnology Center, Eli Lilly and Company, USA |
 |
Dr. Joerg Grosse-Onnebrink, Head, University Children’s Hospital Münster, Germany |
 |
Dr. Steve Gardner, CEO, PrecisionLife Ltd, UK |
 |
Dr. Zhenghong Qin, Professor, Soochow University School of Pharmaceutical Science, China |
 |
Dr. Monika Tandon, Senior Vice President & Head, Glenmark Pharmaceuticals, India |
IDDST-2022 provides an ideal platform to showcase your novel technologies and products. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.
Why Reserve a Booth at IDDST-2022
• To Meet Face-to-Face with the International Movers and Shakers
• To Meet with Key Decision Marker
• To Explore Business Opportunities
• To Spotlight Advanced Technologies and Their Scientific and Commercial Applications
• To Take Advantage of the Conference's Captive Audience and Networking Opportunities within the Exhibition
Hall
  |
Exhibition Date: |
 |
 |
 |
 |
 |
 |
 |
 |
International Transmembrane Transporter Society
International Society of Digital Medicine
The Asian Society of Natural Products
UK Pharmacogenetics and Stratified Medicine Network
The Czech Pharmaceutical Society
The National Hospital Pharmacists Association of Romanian
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
© 2003-2022 All rights reserved by BITeomics |